A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Clinical trial NCT06807424 · RECRUITING
Trial details
- NCT number
- NCT06807424
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-09
- Primary completion
- 2027-02-10
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.